Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Contractually, we still expect GPs to deliver primary clinical care to those who need it whilst assessing each individual patients needs and keeping staff and patients safe while they do so
H.BlagosklonnyM
doi: 10.1111/exd.12645 95 ShubbarEVegforsJCarlstromMPeterssonSEnerbackC
elata has also been included in the second-grade protected plants according to the List of National Key Protected Wild Plants (the second batch) (List of National Key Protected Wild Plants, 2023)
